Encodia
Sharon Kedar is a partner at Encodia and a board member at several companies, including Codex DNA, Hawthorne Effect, Inc., and 908 Devices. Sharon has also served on the board of Emulate, Inc. and IsoPlexis. Prior to their work in the private sector, Sharon was a venture capitalist with Northpond Ventures.
Sharon Kedar has an MBA from Harvard Business School and a BA in Economics from Rice University. Sharon is also a Chartered Financial Analyst (CFA) Charterholder.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Encodia
4 followers
Encodia is a privately held biotechnology company bringing the power of sequencing to proteomics. The company's patented ProteoCode technology enables highly scalable protein analysis via an accessible and easy-to-use benchtop instrument. Tools employing Encodia’s ProteoCode technology will drive new biological understanding with impact in data-driven drug discovery and development, new high complexity diagnostics, and beyond.